Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

OptiNose Inc (OPTN)

  • Event
  • June 03, 2022, 11:00 UTC
  • 12
  • 1 comments

(99% Neutral) OPTINOSE, INC. (OPTN) Files Form 8-K

Comment Full text

Applied Therapeutics (APLT)

  • Event
  • June 03, 2022, 11:00 UTC
  • 13
  • 1 comments

(99% Neutral) APPLIED THERAPEUTICS, INC. (APLT) Files Form 8-K

Comment Full text

Y-mAbs Therapeutics Inc (YMAB)

  • Event
  • June 02, 2022, 21:15 UTC
  • 12
  • 1 comments

(99% Neutral) Y-MABS THERAPEUTICS, INC. (YMAB) Announces Executive Changes

Comment Full text

Arcutis Biotherapeutics (ARQT)

  • Event
  • June 02, 2022, 21:15 UTC
  • 12
  • 1 comments

(50% Neutral) ARCUTIS BIOTHERAPEUTICS, INC. (ARQT) Announces Regulatory Update

Comment Full text

Apellis Pharmaceuticals Inc (APLS)

  • Event
  • June 02, 2022, 20:30 UTC
  • 12
  • 1 comments

(99% Neutral) Apellis Pharmaceuticals, Inc. (APLS) Announces Regulatory Update

Comment Full text

Myriad Genetics Inc (MYGN)

  • Event
  • June 02, 2022, 20:30 UTC
  • 11
  • 1 comments

(99% Neutral) MYRIAD GENETICS, INC. (MYGN) Announces Executive Changes

Comment Full text

Intercept Pharmaceuticals Inc (was acquisited by Alfasigma (Italy) on 08/11/2023) (ICPT)

  • Event
  • June 02, 2022, 20:06 UTC
  • 12
  • 1 comments

(99% Neutral) Intercept Pharmaceuticals, Inc. (ICPT) Announces Executive Departure

Comment Full text

Xenon Pharmaceuticals Inc (XENE)

  • Event
  • June 02, 2022, 20:03 UTC
  • 12
  • 1 comments

(99% Neutral) XENON PHARMACEUTICALS INC. (XENE) Announces Executive Changes

Comment Full text

Ascendis Pharma (ASND)

  • Event
  • June 02, 2022, 20:01 UTC
  • 11
  • 1 comments

(99% Neutral) Ascendis Pharma (ASND) Announces 2027 Annual General Meeting

Comment Full text

Protagonist Therapeutics Inc (PTGX)

  • Event
  • June 02, 2022, 20:00 UTC
  • 12
  • 1 comments

(99% Neutral) PROTAGONIST THERAPEUTICS, INC. (PTGX) Announces Regulatory Update

Comment Full text
  • Previous
  • 200
  • 201
  • 202
  • 203
  • 204
  • Next

Search

News categories

  • Technical Exchange News(10894)
  • Event(2288)
  • SEC News(189958)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124719)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin